Meanwhile, Liu et al. developed a dual targeted theranostic probe based on TPECM with activatable PDT for targeted cancer cell ablation.49 The probe contains a cRGD peptide to target integrins overexpressed on the cancer cell surface with a second peptide sequence to respond to cathepsin B enzymes overexpressed in cancer cell lysosomes. This evidence concerns the gene CTSB and cancer.